Navigation Links
Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
Date:8/6/2013

strative expenses. As of June 30, 2013, Orexigen had $55.8 million in cash and cash equivalents and an additional $40.2 million in marketable securities, for a total of $96.0 million.

Product candidates: Contrave (32 mg naltrexone sustained-release (SR)/360 mg bupropion SR) for the treatment of obesity: In 2012, Orexigen screened more than 13,000 patients, enrolled more than 10,400 and ultimately completed recruitment of the Light Study with approximately 8,900 randomized patients. The primary objective of the double-blind, randomized, placebo-controlled Light Study, which Orexigen is conducting under a Special Protocol Assessment with the FDA (United States Food and Drug Administration), is to rule out excess cardiovascular risk in overweight and obese patients receiving Contrave. An interim analysis and NDA resubmission is planned once the independent Data Monitoring Committee (DMC) has determined that sufficient information has been gathered for the analysis that would include at least 87 adjudicated major adverse cardiovascular events (MACE). Orexigen enrolled into the Light Study a patient population that the company predicted would have an annualized MACE rate between 1% and 2%. Orexigen is preparing to be ready to conduct the interim analysis and resubmit the Contrave NDA in the remaining months of 2013. Orexigen has licensed North American commercial rights to Takeda Pharmaceuticals. Orexigen owns Contrave rights throughout the rest of the world and intends to license commercial rights outside North America.

Empatic™, a fixed dose combination of bupropion SR and zonisamide SR, for the treatment of obesity: In a series of discussions with the FDA on the continued development of Empatic, the FDA stated that Phase 3 data for Empatic may be sufficient to support submission of an NDA without data from a cardiovascular outcomes trial. The FDA indicated that as long as the placebo-subtracted changes in body weight, blood pressure
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Orexigen Therapeutics to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 2015  SI-BONE, Inc., a medical device company ... System, a minimally invasive surgical (MIS) device indicated ... (SI) joint, announced today that Martin Watson ... effective January 1, 2015.  Mr. Watson is currently ... LLC.  Prior to Fidelity, Mr. Watson was the ...
(Date:4/20/2015)... 2015  Fewer blockbusters drugs are expected to go ... for generic companies in Asia . ... beyond the patent cliff to focus on market expansion ... generic manufacturers are restructuring their business models and investing ... the impact of these efforts will take a minimum ...
(Date:4/20/2015)... This report analyzes the worldwide markets for ADME-Toxicology Testing in ... In-Vitro), and ADME Testing. The report provides separate comprehensive analytics ... Japan , Europe , ... forecasts are provided for the period 2014 through 2020. Also, ... data and analytics are derived from primary and secondary research. ...
Breaking Medicine Technology:SI-BONE, Inc. Announces Appointment of Fidelity Health Insurance Services, LLC's Martin Watson to Board of Directors 2SI-BONE, Inc. Announces Appointment of Fidelity Health Insurance Services, LLC's Martin Watson to Board of Directors 3Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 2Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 3Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 4Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 5World ADME-Toxicology Testing Industry 2World ADME-Toxicology Testing Industry 3World ADME-Toxicology Testing Industry 4World ADME-Toxicology Testing Industry 5World ADME-Toxicology Testing Industry 6World ADME-Toxicology Testing Industry 7World ADME-Toxicology Testing Industry 8World ADME-Toxicology Testing Industry 9World ADME-Toxicology Testing Industry 10World ADME-Toxicology Testing Industry 11World ADME-Toxicology Testing Industry 12World ADME-Toxicology Testing Industry 13World ADME-Toxicology Testing Industry 14World ADME-Toxicology Testing Industry 15World ADME-Toxicology Testing Industry 16World ADME-Toxicology Testing Industry 17World ADME-Toxicology Testing Industry 18World ADME-Toxicology Testing Industry 19
... N.C., Aug. 12, 2011 Although medical devices ... complexities require medical device companies to invest more ... generic pharmaceutical products.   Tactical marketers ... activities, such as troubleshooting post-launch and managing product ...
... Misonix, Inc. (NASDAQ: MSON ), a ... innovative therapeutic ultrasonic products worldwide for wound debridement, ... other surgical and medical applications, has entered into ... Solutions Australasia Pty. Ltd., based in Newport, Victoria, ...
Cached Medicine Technology:Medical Device Marketing Groups Focus More Resources on Tactical Activities When Compared to Pharmaceutical Counterparts 2Misonix Announces New Distribution Agreement for Australia and New Zealand 2Misonix Announces New Distribution Agreement for Australia and New Zealand 3
(Date:4/21/2015)... 21, 2015 Now, busy Diet Doc clients ... company’s new diet breakfast omelets. Like Diet Doc’s ... in dry ice and are delivered directly to their door. ... southwestern omelets that not only appeal to the taste buds, ... ideal weight with healthy, low carbohydrate meals. , One ...
(Date:4/21/2015)... 2015 Pharmacy point of sale ... year's Independent Pharmacy Cooperative trade show, to be held ... Beach. , Retail Management Solutions recently became an approved ... Mike Gross, VP of Sales and Marketing. Gross says ... pharmacy trade shows in the country -- and this ...
(Date:4/21/2015)... Lifeguard Master is out with their new ... listed on the Lifeguard Master website and are in stock. ... want a quality and flexible product during their rescue efforts. ... color Spider Straps are some of the most popular items ... sturdy, heavy nylon” , The Spider Straps are rated superior ...
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 The ... at the beautiful Governor’s Academy prep school in Byfield, ... July 10-12, 2015, for boys entering grades 6-12. , ... and supplement the players’ fall coaching. , ... athletes. Not only are these the most unsung positions ...
(Date:4/21/2015)... 2015 Renewable energy, sustainable living, the ... the Earth Day topics USM Studios ’ programming ... debate the affect of climate change on the planet, ... matter touching on the environmental concerns affecting the nation ... into sustainable lifestyles, clean air options, and much more ...
Breaking Medicine News(10 mins):Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 2Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 3Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 4Health News:Retail Management Solutions to Attend Upcoming Independent Pharmacy Cooperative Trade Show 2Health News:Retail Management Solutions to Attend Upcoming Independent Pharmacy Cooperative Trade Show 3Health News:New Spider Straps for Spine Boards are Introduced for Easy, Fast, and Convenient Use 2Health News:New Spider Straps for Spine Boards are Introduced for Easy, Fast, and Convenient Use 3Health News:New Spider Straps for Spine Boards are Introduced for Easy, Fast, and Convenient Use 4Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:USM Studios’ Programming Focuses on the Environment 2
... Md., May 7 Vaccinogen Inc. said Dutch health,authorities ... immediately clearing the path to more than $100 million ... company,s facility based in Emmen, The,Netherlands also paves the ... -- the final step before the vaccine can be ...
... Holdings Corp. (Nasdaq:,HMSY) today announced that it will present ... be held May 13-15, 2008 at the Four,Seasons in ... Walter Hosp, Chief Financial,Officer of HMS Holdings Corp., will ... HMS Holdings Corp. (Nasdaq: HMSY ) is the ...
... technology will enable physicians to have secure access to, online patient ... ... telephones, MANCHESTER, N.H., May 7 New Hampshire physicians ... Anthem patients, virtually anywhere they can receive an internet,signal, thanks to an ...
... U.S. Department,of Health and Human Services published an update ... Tobacco Use and Dependence,which contains revised and improved recommendations ... smokers in quitting. The,guideline also confirms that there has ... right now., With the release of these new ...
... May 7 /PRNewswire-USNewswire/ - The International,Academy of Compounding ... doctors in applauding the introduction of H. Con. ... and Drug Administration,s,(FDA) new policy restricting women,s access ... interest" and calling on the FDA to,"reverse its ...
... Pa., May 7 Select Medical Corporation,will release the ... on Thursday, May 15, 2008., The Company will ... Wednesday, May 21, 2008, at 11:00am EDT. The domestic ... dial in number is,1-210-839-8503. The passcode for the call ...
Cached Medicine News:Health News:Dutch Authorize Manufacture of Vaccinogen's New Cancer Vaccine; License Clears Path to European Production, Final FDA Trial 2Health News:Anthem Blue Cross and Blue Shield in New Hampshire Announces Unique Enhancement to its ePrescribing Program 2Health News:Anthem Blue Cross and Blue Shield in New Hampshire Announces Unique Enhancement to its ePrescribing Program 3Health News:New Smoking Cessation Guideline Confirms That Now is the Time to Quit Smoking 2Health News:Patients, Doctors, Pharmacists Praise Bipartisan House Resolution on Compounded Hormones Containing Estriol 2Health News:Patients, Doctors, Pharmacists Praise Bipartisan House Resolution on Compounded Hormones Containing Estriol 3
... and urethral pressure profilometry. Dual ... to be filled while cystometry ... catheter design enhances visualization during ... in peel-open packages. Intended for ...
... Scientifics SAFE-T-FILL Capillary Blood Collection Tubes are ... for a wide range of applications, the ... capillary tube, attached cap and a micro ... draw the blood into the micro tube ...
... RAM Scientifics SAFE-T-FILL Capillary Blood Collection ... systems. Available for a wide range of ... with a capillary tube, attached cap and ... action to draw the blood into the ...
... RAM Scientifics SAFE-T-FILL Capillary Blood Collection Tubes ... Available for a wide range of applications, ... a capillary tube, attached cap and a ... to draw the blood into the micro ...
Medicine Products: